https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 Serum concentrations of selenium and copper in patients diagnosed with pancreatic cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:23842 Wed 11 Apr 2018 14:23:39 AEST ]]> Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:19379 Wed 11 Apr 2018 14:19:24 AEST ]]> Can selenium levels act as a marker of colorectal cancer risk? https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:14831 Wed 11 Apr 2018 13:24:36 AEST ]]> Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:20582 Sat 24 Mar 2018 07:55:36 AEDT ]]> Selenium and cancer https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:25547 Sat 24 Mar 2018 07:26:05 AEDT ]]> Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:35067 853.0–973.9 μg/l). Among five analyzed genetic variants, rs11568818 in MMP-7 appeared to be correlated with 2-fold increased prostate cancer risk (OR = 2.39, 95% CI = 1.19–4.82, p = 0.015). Conclusion: Our results suggest a significant correlation of higher serum zinc levels with the diagnosis of prostate cancer. The polymorphism rs11568818 in MMP-7 gene was also associated with an increased prostate cancer risk in Poland.]]> Mon 17 Jun 2019 14:15:45 AEST ]]> Serum 25(OH)D concentration, common variants of the VDR gene and lung cancer occurrence https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:32347 Fri 25 May 2018 13:33:02 AEST ]]>